Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 11 de 11
Filtrer
1.
BMC Med Imaging ; 22(1): 84, 2022 05 10.
Article de Anglais | MEDLINE | ID: mdl-35538520

RÉSUMÉ

OBJECTIVE: To investigate whether radiomics based on ultrasound images can predict lymphovascular invasion (LVI) of rectal cancer (RC) before surgery. METHODS: A total of 203 patients with RC were enrolled retrospectively, and they were divided into a training set (143 patients) and a validation set (60 patients). We extracted the radiomic features from the largest gray ultrasound image of the RC lesion. The intraclass correlation coefficient (ICC) was applied to test the repeatability of the radiomic features. The least absolute shrinkage and selection operator (LASSO) was used to reduce the data dimension and select significant features. Logistic regression (LR) analysis was applied to establish the radiomics model. The receiver operating characteristic (ROC) curve, calibration curve, and decision curve analysis (DCA) were used to evaluate the comprehensive performance of the model. RESULTS: Among the 203 patients, 33 (16.7%) were LVI positive and 170 (83.7%) were LVI negative. A total of 5350 (90.1%) radiomic features with ICC values of ≥ 0.75 were reported, which were subsequently subjected to hypothesis testing and LASSO regression dimension reduction analysis. Finally, 15 selected features were used to construct the radiomics model. The area under the curve (AUC) of the training set was 0.849, and the AUC of the validation set was 0.781. The calibration curve indicated that the radiomics model had good calibration, and DCA demonstrated that the model had clinical benefits. CONCLUSION: The proposed endorectal ultrasound-based radiomics model has the potential to predict LVI preoperatively in RC.


Sujet(s)
Tumeurs du rectum , Aire sous la courbe , Humains , Courbe ROC , Tumeurs du rectum/imagerie diagnostique , Tumeurs du rectum/chirurgie , Études rétrospectives , Échographie
2.
Cancer Biother Radiopharm ; 35(9): 696-710, 2020 Nov.
Article de Anglais | MEDLINE | ID: mdl-32401038

RÉSUMÉ

Background: The molecular mechanisms underlying gastric cancer (GC) progression are unclear. The authors examined key genes associated with the prognosis and tumor-infiltrating immune cells in patients with GC. Materials and Methods: Gene expression omnibus (GEO) was used to filter and obtain GC-related differentially expressed genes (DEGs). The molecular functions, biological processes, and cellular components of the DEGs were subjected to enrichment analysis. Protein-protein interaction networks of proteins encoded by the DEGs were analyzed using STRING. The authors also identified hub genes of GC, as well as their expression levels in GC and their relationship with patient prognosis. The relationship between hub genes and tumor-infiltrating immune cells was analyzed by Tumor IMmune Estimation Resource. Results: Six GEO datasets were included in this study, and 265 DEGs were identified. These DEGs were enriched in different signaling pathways and had different biological functions. Six hub genes were potentially significantly related to the molecular mechanisms of GC (TOP2A, FN1, SPARC, COL3A1, COL1A1, and TIMP1). These genes are potential markers of prognosis. Five hub genes were significantly positively correlated with the number of macrophages, neutrophils, and dendritic cells. Conclusions: The authors provide a theoretical basis for exploring the molecular regulation mechanism underlying GC and identifying therapeutic targets.


Sujet(s)
Marqueurs biologiques tumoraux/génétique , Régulation de l'expression des gènes tumoraux/immunologie , Tumeurs de l'estomac/mortalité , Microenvironnement tumoral/immunologie , Biologie informatique , Jeux de données comme sujet , Cellules dendritiques/immunologie , Gastrectomie , Muqueuse gastrique/immunologie , Muqueuse gastrique/anatomopathologie , Muqueuse gastrique/chirurgie , Humains , Estimation de Kaplan-Meier , Lymphocytes TIL/immunologie , Granulocytes neutrophiles/immunologie , Pronostic , Cartes d'interactions protéiques/génétique , Transduction du signal/génétique , Transduction du signal/immunologie , Tumeurs de l'estomac/génétique , Tumeurs de l'estomac/immunologie , Tumeurs de l'estomac/chirurgie , Taux de survie , Microenvironnement tumoral/génétique , Macrophages associés aux tumeurs/immunologie
3.
Oncol Rep ; 43(6): 1915-1927, 2020 06.
Article de Anglais | MEDLINE | ID: mdl-32186781

RÉSUMÉ

Tumor recurrence following radiofrequency ablation (RFA) treatment in liver cancer is an important factor affecting patient prognosis. Furthermore, the biological role of long non­coding RNAs (lncRNAs) in residual hepatoblastoma (HB) tissues after RFA remains largely unknown. By using microarray technology, this study investigated the expression of lncRNAs and mRNAs among four pairs of HB tissues (incomplete ablation treatment and no treatment) in a nude mouse subcutaneous xenograft model. Subsequently, bioinformatics analysis was used to understand the functions and pathways of the identified mRNAs. Finally, a connectivity map (CMap) analysis was conducted to identify potential therapeutic strategies for residual HB tissues. Compared with the untreated nude mouse subcutaneous xenograft model, in the experimental group, a significant difference in the expression of 740 lncRNAs and 663 mRNAs was detected. Subsequently, bioinformatics analysis revealed that the differentially expressed mRNAs were significantly enriched in pathways associated with antigen processing, the presentation of endogenous antigens, the regulation of cellular metabolic processes, MAPK signaling and cell cycle regulation. Additionally, six compounds (valproic acid, metformin, tanespimycin, wortmannin, fulvestrant and MK­886) were identified by CMap analysis as potential therapeutic agents for the treatment of residual HB tissues. These findings provide a novel insight into the pathogenesis of residual HB and potential therapeutic strategies for aggressive tumor recurrence following RFA treatment in patients with HB.


Sujet(s)
Analyse de profil d'expression de gènes/méthodes , Réseaux de régulation génique , Hépatoblastome/anatomopathologie , Tumeurs du foie/anatomopathologie , Récidive tumorale locale/anatomopathologie , ARN long non codant/génétique , Animaux , Antinéoplasiques/pharmacologie , Antinéoplasiques/usage thérapeutique , Régulation de l'expression des gènes tumoraux/effets des médicaments et des substances chimiques , Réseaux de régulation génique/effets des médicaments et des substances chimiques , Cellules HepG2 , Hépatoblastome/traitement médicamenteux , Hépatoblastome/génétique , Humains , Tumeurs du foie/traitement médicamenteux , Tumeurs du foie/génétique , Mâle , Souris , Souris nude , Thérapie moléculaire ciblée , Récidive tumorale locale/traitement médicamenteux , Récidive tumorale locale/génétique , Séquençage par oligonucléotides en batterie , Ablation par radiofréquence , Tests d'activité antitumorale sur modèle de xénogreffe
4.
Oncol Rep ; 40(6): 3346-3358, 2018 Dec.
Article de Anglais | MEDLINE | ID: mdl-30272308

RÉSUMÉ

As one of the most lethal malignancies worldwide, hepatocellular carcinoma (HCC) has a high mortality rate, which is mainly due to the complex and multi­step aberrations in gene expression associated with it. Small nucleolar RNAs (snoRNAs), non­coding RNAs that are 60­300 nucleotides in length, have been proposed to be closely associated with numerous human diseases, including HCC. However, the current knowledge regarding their clinical significance and mechanistic roles in HCC is limited. The present study comprehensively analyzed the snoRNA expression profiles in HCC and identified several ones that were dysregulated. The potential regulatory mechanisms of these snoRNAs were assessed via gene functional enrichment analyses. Univariate and multivariate Cox regression analyses were performed to identify snoRNAs that are independently associated with the risk of mortality. Subsequently, a prognostic index (PI) for survival prediction was established, which may serve as a prognostic biomarker for patients with HCC (hazard ratio, 3.023; 95% confidence interval: 1.785­5.119; P<0.001). In addition, a series of bioinformatics analyses were performed to identify potential differences in the perturbation of pathways between high­ and low­risk groups. The PI developed in the present study was determined to have a moderate predictive value regarding the clinical outcome for HCC patients.


Sujet(s)
Carcinome hépatocellulaire/génétique , Analyse de profil d'expression de gènes/méthodes , Tumeurs du foie/génétique , Petit ARN nucléolaire/génétique , Cartographie chromosomique , Femelle , Régulation de l'expression des gènes tumoraux , Réseaux de régulation génique , Humains , Mâle , Pronostic , 12465 , Analyse de survie
5.
Cancer Cell Int ; 18: 74, 2018.
Article de Anglais | MEDLINE | ID: mdl-29780284

RÉSUMÉ

BACKGROUND: Dysregulated expression of long non-coding RNAs (lncRNAs) has been reported in the pathogenesis and progression of multiple cancers, including hepatocellular carcinoma (HCC). LncRNA CTD-2547G23.4 is a novel lncRNA, and its role in HCC is still unknown. Here, we aimed to clarify the expression pattern and clinical value of CTD-2547G23.4 and to investigate the prospective regulatory mechanism via bioinformatics analysis in HCC. METHODS: To identify differentially expressed lncRNAs in HCC, we downloaded RNA-Seq data for HCC and adjacent non-tumour tissues via The Cancer Genome Atlas (TCGA). CTD-2547G23.4 was selected by using the R language and receiver operating characteristic curve analysis. Furthermore, we validated the differential expression of CTD-2547G23.4 via Gene Expression Omnibus (GEO), ArrayExpress, Oncomine databases and quantitative real-time polymerase chain reaction (qRT-PCR). The relationship between the CTD-2547G23.4 level and clinic pathological parameters was also assessed. To further probe the role of CTD-2547G23.4 in HCC cell cycle, lentivirus-mediated small interfering RNA was applied to silence CTD-2547G23.4 expression in Huh-7 cell line. In addition, the related genes of CTD-2547G23.4 gathered from The Atlas of Noncoding RNAs in Cancer (TANRIC) database and Multi Experiment Matrix (MEM) were assessed with Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes, Protein Analysis Through Evolutionary Relationships and protein-protein interaction (PPI) networks. RESULTS: CTD-2547G23.4 expression was remarkably higher in 370 HCC tissue samples than that in adjacent non-tumour liver tissues (48.762 ± 27.270 vs. 14.511 ± 8.341, P < 0.001) from TCGA dataset. The relative expression level of CTD-2547G23.4 in HCC was consistently higher than that in adjacent non-cancerous tissues (2.464 ± 0.833 vs. 1.813 ± 0.784, P = 0.001) as assessed by real time RT-qPCR. The area under the curve of the summary receiver operating characteristic curve was 0.8720 based on TCGA, qRT-PCR and GEO data. Further analysis indicated that the increased expression levels of CTD-2547G23.4 were associated with the neoplasm histologic grade and vascular tumour cell type. The expression of CTD-2547G23.4 was significantly downregulated in CTD-2547G23.4 knockdown cells. Moreover, cell cycle analysis revealed that CTD-2547G23.4 depletion in Huh-7 cell line led to S phase arrest. Furthermore, 314 related genes identified by TANRIC and MEM databases were processed with a pathway analysis. The bioinformatics analysis indicated that CTD-2547G23.4 might play a key role in the progress of HCC through four hub genes, SRC, CREBBP, ADCY8 and PPARA. CONCLUSIONS: Collectively, we put forward the hypothesis that the novel lncRNA CTD-2547G23.4 may act as an exceptional clinical index and promote the HCC tumourigenesis and progression via various related genes.

6.
Int J Oncol ; 53(2): 603-619, 2018 Aug.
Article de Anglais | MEDLINE | ID: mdl-29749543

RÉSUMÉ

Thyroid cancer (TC) is the most common endocrine malignancy, accounting for approximately 90% of all malignancies of the endocrine system. Despite the fact that patients with TC tend to have good prognoses, the high incidence rate and lymph node metastases remain unresolved issues. Autophagy is an indispensable process that maintains intracellular homeostasis; however, the role of autophagy in several steps of the initiation and progression of TC has not yet been elucidated. In this study, we first identified several autophagy-related genes (ARGs) that were provoked in the onset of TC. Subsequently, a bioinformatics analysis hinted that these genes were markedly disturbed in several proliferative signaling pathways. Moreover, we demonstrated that the differentially expressed ARGs were closely related to several aggressive clinical manifestations, including an advanced tumor stage and lymph node metastasis. Our study further selected prognostic ARGs and developed a prognostic signature based on three key genes (ATG9B, BID and B1DNAJB1), which displayed a moderate ability to predict the prognosis of TC. On the whole, the findings of this study demonstrate that ARGs disrupt proliferation-related pathways and consequently lead to aggressive clinical manifestations. These findings provide insight into the potential molecular mechanisms of action of ARGs and their clinical significance, and also provide classification information of potential therapeutic significance.


Sujet(s)
Protéines associées à l'autophagie/génétique , Analyse de profil d'expression de gènes/méthodes , Réseaux de régulation génique , Tumeurs de la thyroïde/génétique , Tumeurs de la thyroïde/anatomopathologie , Autophagie , Protéine Bid/génétique , Prolifération cellulaire , Évolution de la maladie , Femelle , Régulation de l'expression des gènes tumoraux , Protéines du choc thermique HSP40/génétique , Humains , Métastase lymphatique , Mâle , Protéines membranaires/génétique , Stadification tumorale , Pronostic , Études prospectives
7.
Sichuan Da Xue Xue Bao Yi Xue Ban ; 47(2): 174-9, 2016 Mar.
Article de Chinois | MEDLINE | ID: mdl-27263289

RÉSUMÉ

OBJECTIVE: To investigate the expression of type 3 acid-sensing ion channels (ASIC3) in bladder tissue of over active bladder (OAB) rat model. METHODS: Sixty adult female rats were randomly divided into control group (intraperitoneal injection of 0.9% sodium chloride), GAB group (intraperitoneal injection of cyclophosphamide) and the intervention group (OAB rats treated with ASIC3 inhibitor amiloride). The rats underwent urodynamic testing. The bladder tissues were collected for pathological examination, while the expressions of ASIC3 were measured by the methods of immunohistochemistry, RT-PCR and Western blot. RESULTS: Urodynamic study found that the rats in control group had no significant contraction instability in both storage and voiding stages. Compared with the control group, OAB group and intervention group showed instability of visible contraction in urine storage stage, with shorter micturition interval (P < 0.01) and increased frequency of urination (P < 0.01). Compared with the OAB group, the intervention group showed significantly prolonged micturition interval (P < 0.05) and reduced frequency of urination (P < 0.05). Pathologic examination showed rat bladder mucosal damage in both OAB group and intervention group. Immunohistochemistry found the expression of ASIC3 on bladder mucosa. RT-PCR and Western blot showed significantly higher expression of ASIC3 in OAB group (P < 0.01), but the expression of ASIC3 decreased in intervention group after adding ASIC3 inhibitor. CONCLUSION ASIC3 expresses mainly on bladder mucosa. The gene and protein expression of ASIC3 in rat bladder tissue of OAB rats is higher, which can be significantly decreased by ASIC inhibitor. The symptoms of OAB reduce after intervention, which demonstrates the increased expression of ASIC3 in bladder tissue is closely related to bladder detrusor.


Sujet(s)
Canaux ioniques sensibles à l'acidité/métabolisme , Vessie hyperactive , Vessie urinaire/métabolisme , Amiloride/pharmacologie , Animaux , Technique de Western , Cyclophosphamide/pharmacologie , Modèles animaux de maladie humaine , Femelle , Immunohistochimie , Injections péritoneales , Muqueuse/métabolisme , Rats , Miction , Urodynamique
8.
Tohoku J Exp Med ; 237(1): 57-67, 2015 09.
Article de Anglais | MEDLINE | ID: mdl-26353909

RÉSUMÉ

Vascular dementia (VD) has been one of the most serious public health problems worldwide. It is well known that cerebral hypoperfusion is the key pathophysiological basis of VD, but it remains unclear how global genes in hippocampus respond to cerebral ischemia-reperfusion. In this study, we aimed to reveal the global gene expression profile in the hippocampus of VD using a rat model. VD was induced by repeated occlusion of common carotid arteries followed by reperfusion. The rats with VD were characterized by deficit of memory and cognitive function and by the histopathological changes in the hippocampus, such as a reduction in the number and the size of neurons accompanied by an increase in intercellular space. Microarray analysis of global genes displayed up-regulation of 7 probesets with genes with fold change more than 1.5 (P < 0.05) and down-regulation of 13 probesets with genes with fold change less than 0.667 (P < 0.05) in the hippocampus. Gene Ontology (GO) and pathway analysis showed that the up-regulated genes are mainly involved in oxygen binding and transport, autoimmune response and inflammation, and that the down-regulated genes are related to glucose metabolism, autoimmune response and inflammation, and other biological process, related to memory and cognitive function. Thus, the abnormally expressed genes are closely related to oxygen transport, glucose metabolism, and autoimmune response. The current findings display global gene expression profile of the hippocampus in a rat model of VD, providing new insights into the molecular pathogenesis of VD.


Sujet(s)
Démence vasculaire/génétique , Expression des gènes/génétique , Hippocampe/métabolisme , Animaux , Maladies auto-immunes/immunologie , Sténose carotidienne/complications , Sténose carotidienne/génétique , Sténose carotidienne/physiopathologie , Démence vasculaire/étiologie , Démence vasculaire/métabolisme , Encéphalite/étiologie , Encéphalite/anatomopathologie , Glucose/métabolisme , Mâle , Apprentissage du labyrinthe , Troubles de la mémoire/étiologie , Troubles de la mémoire/génétique , Troubles de la mémoire/psychologie , Analyse sur microréseau , Consommation d'oxygène , Rats , Rat Sprague-Dawley , Lésion d'ischémie-reperfusion/complications , Lésion d'ischémie-reperfusion/génétique , Lésion d'ischémie-reperfusion/physiopathologie , Régulation positive
9.
Mol Med Rep ; 12(3): 4273-4283, 2015 Sep.
Article de Anglais | MEDLINE | ID: mdl-26094797

RÉSUMÉ

Apoptosis and the dysfunction of the cyclic adenosine monophosphate (cAMP)/protein kinase A (PKA)/cAMP-responsive element binding protein (CREB) signaling pathway have a key role in memory impairment in vascular dementia (VaD), a challenging clinical problem. Yifei Xuanfei Jiangzhuo formula (YXJF), a Chinese herbal decoction, has been used to treat VaD in clinical practice and has produced positive outcomes; however, convincing evidence is currently lacking. The present study aimed to investigate the effects of YXJF on memory impairment in rats with cerebral ischemia/reperfusion and to explore the underlying mechanism. YXJF ameliorated memory impairment in rats with cerebral ischemia/reperfusion, inhibited hippocampal apoptosis in a dose-dependent manner and attenuated increases in the protein expression of B-cell lymphoma 2 (Bcl-2)-associated X protein as well as c-Jun and a reduction in Bcl-2 protein expression in the hippocampal tissue of the rats. Furthermore, administration of YXJF significantly increased the protein expression of PKA C-α and CREB, and promoted CREB phosphorylation. The results indicated that YXJF improves memory impairment through inhibiting apoptosis and enhancing PKA/CREB signal transduction in rats with cerebral ischemia/reperfusion.


Sujet(s)
Encéphalopathie ischémique/traitement médicamenteux , Médicaments issus de plantes chinoises/pharmacologie , Troubles de la mémoire/traitement médicamenteux , Neuroprotecteurs/pharmacologie , Lésion d'ischémie-reperfusion/traitement médicamenteux , Animaux , Apoptose , Protéines régulatrices de l'apoptose/génétique , Protéines régulatrices de l'apoptose/métabolisme , Encéphalopathie ischémique/complications , Encéphalopathie ischémique/psychologie , Région CA1 de l'hippocampe/effets des médicaments et des substances chimiques , Région CA1 de l'hippocampe/anatomopathologie , Protéine de liaison à l'élément de réponse à l'AMP cyclique/métabolisme , Cyclic AMP-Dependent Protein Kinases/métabolisme , Évaluation préclinique de médicament , Mâle , Apprentissage du labyrinthe , Troubles de la mémoire/étiologie , Neuroprotecteurs/usage thérapeutique , Phosphorylation , Maturation post-traductionnelle des protéines , Rat Sprague-Dawley , Lésion d'ischémie-reperfusion/complications , Lésion d'ischémie-reperfusion/psychologie , Transduction du signal
10.
Mol Med Rep ; 10(1): 555-9, 2014 Jul.
Article de Anglais | MEDLINE | ID: mdl-24788561

RÉSUMÉ

Fulminant hepatic failure is a severe clinical syndrome associated with a high rate of patient mortality. Recent studies have shown that in addition to its hematopoietic effect, erythropoietin (EPO) has multiple protective effects and exhibits antiapoptotic, antioxidant and anti-inflammatory activities. The present study aimed to determine the hepatoprotective effect of EPO and to elucidate the underlying mechanisms using a D-galactosamine (D-GalN)/lipopolysaccharide (LPS)-induced model of acute liver injury. Experimental groups of mice were administered with various doses of EPO (1,000, 3,000 or 10,000 U/kg, intraperitoneal) once per day for 3 days, prior to injection with D-GalN (700 mg/kg)/LPS (10 µg/kg). Mice were sacrificed 8 h after treatment with D­GalN/LPS. Liver function and histopathology, malondialdehyde (MDA), superoxide dismutase (SOD) and glutathione peroxidase (GSH­Px) activities and EPO receptor (EPOR) and phosphatidylinositol 3-kinase (PI3K) mRNA expression were evaluated. D-GalN/LPS administration markedly induced liver injury, as evidenced by elevated levels of serum aminotransferases, as well as histopathological changes. Compared with the D-GalN/LPS group, pretreatment with EPO significantly decreased the levels of aspartate aminotransferase, alanine aminotransferase and MDA, and increased the activities of SOD and GSH-Px. Furthermore, the protective effects of EPO were paralleled by an upregulation in the mRNA expression of EPOR and PI3K. These data suggest that EPO can ameliorate D-GalN/LPS-induced acute liver injury by reducing oxidative stress and upregulating the mRNA expression of EPOR and PI3K.


Sujet(s)
Érythropoïétine/pharmacologie , Galactosamine/toxicité , Lipopolysaccharides/toxicité , Défaillance hépatique aigüe/induit chimiquement , Agents protecteurs/pharmacologie , Alanine transaminase/sang , Animaux , Aspartate aminotransferases/sang , Modèles animaux de maladie humaine , Époétine alfa , Glutathione peroxidase/métabolisme , Foie/enzymologie , Foie/métabolisme , Foie/anatomopathologie , Défaillance hépatique aigüe/métabolisme , Défaillance hépatique aigüe/anatomopathologie , Malonaldéhyde/métabolisme , Souris , Souris de lignée BALB C , Phosphatidylinositol 3-kinase/génétique , Phosphatidylinositol 3-kinase/métabolisme , ARN messager/métabolisme , Récepteur érythropoïétine/génétique , Récepteur érythropoïétine/métabolisme , Protéines recombinantes/pharmacologie , Superoxide dismutase/métabolisme
11.
Guang Pu Xue Yu Guang Pu Fen Xi ; 22(3): 381-3, 2002 Jun.
Article de Chinois | MEDLINE | ID: mdl-12938309

RÉSUMÉ

Thermal deformation can be caused by high partial heat flux and greatly reduce thermal reliability of electronic devices. In this paper, an attempt is made to measure the thermal deformation of high power electronic devices under working condition using laser holographic interferometry with double exposure. Laser holographic interferometry is an untouched measurement with measurement precision up to micron dimension. The electronic device chosen for measurement is a type of solid state relay which is used for ignition of rockets. The output circuit of the solid state relay is made up of a MOSFET chip and the power density of the chip can reach high value. In particular situations thermal deformation and stress may significantly influence working performance of the solid state relay. The bulk deformation of the chip and its mount is estimated by number of interferential stripes on chip surface. While thermal stress and deformation can be estimated by curvature of interferential stripes on chip surface. Experimental results indicate that there are more interferential stripes on chip surface and greater flexural degree of stripes under high power. Therefore, these results reflect large out-of-plain displacement and deformed size of the chip with the increase of load current.


Sujet(s)
Électronique/instrumentation , Sécurité du matériel , Température élevée , Holographie , Interférométrie , Lasers , Thermomètres
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE